Target intelligence / Profile preview

Host intestinal epithelial cell glycans and gangliosides

Molecular classification
Glycan, Glycosphingolipid, Ganglioside, Receptor
01

Overview

Host intestinal epithelial cell glycans and gangliosides are complex carbohydrate structures and sialic acid-containing glycosphingolipids located on the apical surface of enterocytes (Varki et al., 2017). They serve as critical attachment sites and receptors for a wide variety of enteric pathogens, including bacteria like Vibrio cholerae and viruses such as Rotavirus (Schengrund, 2015; Ramani et al., 2016). For instance, the ganglioside GM1 is the primary receptor for the cholera toxin, facilitating its entry into the cell and subsequent induction of secretory diarrhea (Schengrund, 2015). Beyond pathogen binding, these molecules play essential roles in maintaining the intestinal barrier, mediating cell-cell interactions, and modulating local immune responses (Varki et al., 2017). Therapeutic strategies targeting these structures often involve the use of glycan decoys, such as human milk oligosaccharides, to competitively inhibit pathogen attachment (Ramani et al., 2016). Understanding the diversity of these glycans is crucial for developing treatments against infectious diseases and inflammatory bowel conditions.

Other names
Intestinal glycoconjugatesEnterocyte surface glycansSialic acid-containing glycosphingolipidsMucosal glycansIEC glycansGM1 gangliosideIntestinal cell surface carbohydratesEnterocyte glycocalyx
02

Mechanism of action

Competitive inhibition of pathogen and toxin binding to host cell surface glycoconjugates, or enzymatic modification of these receptors to prevent attachment.

03

Biological functions

Signal transductionImmune responseCell-cell recognitionPathogen attachmentBarrier function
04

Disease associations

InfectionInflammationCancer
05

Safety considerations

Risk of autoimmune responses such as Guillain-Barré syndrome due to molecular mimicryDisruption of normal cell-cell signaling and barrier integrityPotential alteration of the commensal gut microbiota
06

Interacting drugs

Bismuth subsalicylate

5 more in the full profile.

07

Biomarkers

FUT2 (Fucosyltransferase 2) statusGM1 ganglioside expression levelsLewis blood group antigens

Beyond the preview

Go deeper on Host intestinal epithelial cell glycans and gangliosides.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host intestinal epithelial cell glycans and gangliosides.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call